Administration of Rifaximin to improve Liver Regeneration and Outcome following Major Liver Resection

Trial Profile

Administration of Rifaximin to improve Liver Regeneration and Outcome following Major Liver Resection

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2015

At a glance

  • Drugs Rifaximin (Primary)
  • Indications Liver disorders
  • Focus Therapeutic Use
  • Acronyms ARROW
  • Most Recent Events

    • 20 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top